Subsets of ATP-sensitive potassium channel (K ATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of sur expression

FEBS Letters

Volumn 586, Issue 1, 2012, Pages 27-31

  Bodenstine, Thomas M ^a,d   Vaidya, Kedar S ^a   Ismail, Aimen ^a   Beck, Benjamin H ^a   Diers, Anne R ^a   Edmonds, Mick D ^a   Kirsammer, Gina T ^c   Landar, Aimee ^a   Welch, Danny R ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Children's Memorial Research Center   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Gap junction; Glibenclamide; K ATP; Sulfonylurea

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL BLOCKING AGENT; CALCEIN; GLIBENCLAMIDE; POTASSIUM CHANNEL BLOCKING AGENT; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; SULFONYLUREA RECEPTOR 2; SUM 159; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL COMMUNICATION; CELL SPECIFICITY; CONTROLLED STUDY; DRUG TARGETING; GAP JUNCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ATP-BINDING CASSETTE TRANSPORTERS; CELL COMMUNICATION; CELL LINE, TUMOR; GAP JUNCTIONS; HUMANS; KATP CHANNELS; MEDIATOR COMPLEX; NEOPLASM METASTASIS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84655162014     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.11.017     Document Type: Article

References (35)

1. G. Mese, G. Richard, and T.W. White Gap junctions: basic structure and function J. Invest. Dermatol. 127 2007 2516 2524 (Pubitemid 47585051)
2. J.P. Revel, J.H. Hoh, S.A. John, D.W. Laird, K. Puranam, and S.B. Yancey Aspects of gap junction structure and assembly Semin. Cell Biol. 3 1 1992 21 28
3. B.N. Giepmans Gap junctions and connexin-interacting proteins Cardiovasc. Res. 62 2 2004 233 245 (Pubitemid 38496537)
4. P.D. Lampe, and A.F. Lau Regulation of gap junctions by phosphorylation of connexins Arch Biochem. Biophys. 384 2 2000 205 215 (Pubitemid 32012794)
5. G.D. Carystinos, A. Bier, and G. Batist The role of connexin-mediated cell-cell communication in breast cancer metastasis J. Mamm. Gland Biol. Neopl. 6 2001 431 440
6. P.P. Mehta, J.S. Bertram, and W.R. Loewenstein Growth-inhibition of transformed-cells correlates with their junctional communication with normal-cells Cell 44 1986 187 196 (Pubitemid 16036726)
7. M. Mesnil, S. Crespin, J.L. Avanzo, and M.L. Zaidan-Dagli Defective gap junctional intercellular communication in the carcinogenic process Biochim. Biophys. Acta Biomemb. 1719 2005 125 145 (Pubitemid 41785641)
8. G.L. Nicolson, G.E. Gallick, K.M. Dulski, W.H. Spohn, T.M. Lembo, and M.A. Tainsky Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes Oncogene 5 1990 747 753
9. C.C. Naus, and D.W. Laird Implications and challenges of connexin connections to cancer Nat. Rev. Cancer 10 2010 435 441
10. J. Czyz The stage-specific function of gap junctions during tumourigenesis Cell Mol. BioLett. 13 2008 92 102 (Pubitemid 351679947)
11. ATP channels Annu. Rev. Physiol. 60 1998 667 687
12. B. Vera, L.I. Sánchez-Abarca, J.P. Bolaños, and J.M. Medina Inhibition of astrocyte gap junctional communication by ATP depletion is reversed by calcium sequestration FEBS Lett. 392 3 1996 225 228 (Pubitemid 26289118)
13. ATP channel regulates the effect of Ca2+ on gap junction permeability in cultured astrocytes FEBS Lett. 427 1 1998 41 45 (Pubitemid 28210093)
14. A. Velasco, A. Tabernero, B. Granda, and J.M. Medina ATP-sensitive potassium channel regulates astrocytic gap junction permeability by a Ca2+-independent mechanism J. Neurochem. 74 3 2000 1249 1256 (Pubitemid 30104323)
15. R. Sánchez-Alvarez, A. Tabernero, L.I. Sánchez-Abarca, A. Orfao, C. Giaume, and J.M. Medina Proliferation of C6 glioma cells is blunted by the increase in gap junction communication caused by tolbutamide FEBS Lett. 509 2 2001 202 206 (Pubitemid 34015943)
16. R. Sánchez-Alvarez, A. Tabernero, and J.M. Medina The increase in gap junctional communication decreases the rate of glucose uptake in C6 glioma cells by releasing hexokinase from mitochondria Brain Res. 1039 1-2 2005 189 198 (Pubitemid 40386842)
17. R. Sánchez-Alvarez, T. Paíno, S. Herrero-González, J.M. Medina, and A. Tabernero Tolbutamide reduces glioma cell proliferation by increasing connexin43, which promotes the up-regulation of p21 and p27 and subsequent changes in retinoblastoma phosphorylation Glia 54 2 2006 125 134 (Pubitemid 44078134)
18. T. Paíno, E. Gangoso, J.M. Medina, and A. Tabernero Inhibition of ATP-sensitive potassium channels increases HSV-tk/GCV bystander effect in U373 human glioma cells by enhancing gap junctional intercellular communication Neuropharmacology 59 6 2010 480 491
19. S.L. Bowker, S.R. Majumdar, P. Veugelers, and J.A. Johnson Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 2 2006 254 258 (Pubitemid 44106500)
20. T.C. Gray, E. Siegel, R. Govindarajan. Impact of antidiabetic agents on the survival of subjects with colorectal cancer (CRC). J. Clin. Oncol. 28:15s, 2010 (suppl.; abstr. 2586).
21. A.F. Chambers MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res. 69 2009 5292 5293
22. T.M. Bodenstine, K.S. Vaidya, A. Ismail, B.H. Beck, L.M. Cook, A.R. Diers, A. Landar, and D.R. Welch Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition Cancer Res. 70 23 2010 10002 10011
23. M.M. Saunders, M.J. Seraj, Z. Li, Z. Zhou, C.R. Winter, D.R. Welch, and H.J. Donahue Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication Cancer Res. 61 5 2001 1765 1767 (Pubitemid 32691980)
24. P. Kapoor, M.M. Saunders, Z. Li, Z. Zhou, N. Sheaffer, E.L. Kunze, R.S. Samant, D.R. Welch, and H.J. Donahue Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells Int. J. Cancer. 111 5 2004 693 697 (Pubitemid 39062890)
25. Z. Li, Z. Zhou, D.R. Welch, and H.J. Donahue Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs Clin. Exp. Metastasis 25 8 2008 893 901
26. D. Zhu, S. Caveney, G.M. Kidder, and C.C. Naus Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation Proc. Natl. Acad. Sci. USA 88 5 1991 1883 1887 (Pubitemid 21916331)
27. W. Martin, G. Zempel, D. Hülser, and K. Willecke Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions Cancer Res. 51 19 1991 5348 5351
28. I. Legakis, and K. Syrigos Obesity modulation - the role in carcinogenesis Anticancer Agents Med. Chem. 10 6 2010 481 490
29. S.D. Hursting, and N.A. Berger Energy balance, host-related factors, and cancer progression J. Clin. Oncol. 28 26 2010 4058 4065
30. ATP channels Diabetes 47 1998 1412 1418 (Pubitemid 28396944)
31. ATP channels to gliclazide Diabetologia 42 1999 845 848 (Pubitemid 29325075)
32. ATP channels Brit. J. Pharmacol. 133 2001 193 199 (Pubitemid 32500467)
33. M. Dabrowski, P. Wahl, W.E. Holmes, and F.M. Ashcroft Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channel Diabetologia 44 2001 747 756 (Pubitemid 32846030)
34. F.M. Gribble, and F. Reimann Sulphonylurea action revisited: the post-cloning era Diabetologia 46 2003 875 891 (Pubitemid 36961311)
35. M. Horie, M. Watanuki, K. Tsuji, H. Ishida, A. Ishida-Takahashi, Y. Yuzuki, Y. Seino, and S. Sasayama Blockade of cardiac ATP-sensitive K+ channel by cibenzoline targets its pore-forming subunit J. Cardiovasc. Pharmacol. 35 3 2000 434 442 (Pubitemid 30127192)